APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $159,067,182 | -7.0% | 4,146,694 | +42.5% | 0.01% | -12.5% |
| Q1 2024 | $171,022,056 | -2.0% | 2,909,528 | -0.2% | 0.01% | 0.0% |
| Q4 2023 | $174,517,161 | +41.7% | 2,915,422 | -10.0% | 0.01% | +14.3% |
| Q3 2023 | $123,177,857 | -40.8% | 3,238,114 | +41.8% | 0.01% | -36.4% |
| Q2 2023 | $207,989,044 | +5.8% | 2,283,085 | -23.4% | 0.01% | 0.0% |
| Q1 2023 | $196,551,698 | -45.3% | 2,979,862 | -57.1% | 0.01% | 0.0% |
| Q4 2022 | $359,065,346 | +77.8% | 6,943,828 | +134.8% | 0.01% | -15.4% |
| Q3 2022 | $201,982,000 | +27.7% | 2,957,273 | -15.4% | 0.01% | +44.4% |
| Q2 2022 | $158,131,000 | +7.1% | 3,496,925 | +20.3% | 0.01% | +28.6% |
| Q1 2022 | $147,677,000 | +14.9% | 2,906,456 | +6.9% | 0.01% | +16.7% |
| Q4 2021 | $128,572,000 | +38.0% | 2,719,368 | -3.8% | 0.01% | +20.0% |
| Q3 2021 | $93,151,000 | -24.3% | 2,826,195 | +45.2% | 0.01% | -16.7% |
| Q2 2021 | $123,048,000 | +30.4% | 1,946,968 | -11.4% | 0.01% | +20.0% |
| Q1 2021 | $94,341,000 | -32.1% | 2,198,573 | -9.6% | 0.01% | -44.4% |
| Q4 2020 | $139,039,000 | +60.9% | 2,430,753 | -15.1% | 0.01% | +50.0% |
| Q3 2020 | $86,412,000 | -10.2% | 2,864,159 | -2.8% | 0.01% | -14.3% |
| Q2 2020 | $96,243,000 | +43.8% | 2,946,814 | +17.9% | 0.01% | +16.7% |
| Q1 2020 | $66,942,000 | -4.9% | 2,498,764 | +8.7% | 0.01% | +20.0% |
| Q4 2019 | $70,403,000 | +88.2% | 2,299,235 | +48.1% | 0.01% | +66.7% |
| Q3 2019 | $37,401,000 | -12.9% | 1,552,557 | -8.4% | 0.00% | 0.0% |
| Q2 2019 | $42,959,000 | +106.0% | 1,695,322 | +58.5% | 0.00% | +50.0% |
| Q1 2019 | $20,852,000 | +48.4% | 1,069,343 | +0.4% | 0.00% | +100.0% |
| Q4 2018 | $14,048,000 | -42.1% | 1,065,027 | -21.9% | 0.00% | -50.0% |
| Q3 2018 | $24,258,000 | -8.7% | 1,364,265 | +12.9% | 0.00% | 0.0% |
| Q2 2018 | $26,581,000 | +603.6% | 1,208,204 | +606.8% | 0.00% | – |
| Q1 2018 | $3,778,000 | +81.5% | 170,946 | +78.2% | 0.00% | – |
| Q4 2017 | $2,082,000 | – | 95,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
| Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
| Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
| Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
| Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
| Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
| GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
| Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
| Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
| Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |